AAAAAA

   
Results: 1-16 |
Results: 16
Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS
Authors: Chen, M Gran, B Costello, K Johnson, K Martin, R Dhib-Jalbut, S
Citation: M. Chen et al., Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS, MULT SCLER, 7(4), 2001, pp. 209-219
Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS lyme disease
Authors: Martin, R Gran, B Zhao, YD Markovic-Plese, S Bielekova, B Marques, A Sung, MH Hemmer, B Simon, R McFarland, HF Pinilla, C
Citation: R. Martin et al., Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS lyme disease, J AUTOIMMUN, 16(3), 2001, pp. 187-192
Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands
Authors: Zhao, YD Gran, B Pinilla, C Markovic-Plese, S Hemmer, B Tzou, A Whitney, LW Biddison, WE Martin, R Simon, R
Citation: Yd. Zhao et al., Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands, J IMMUNOL, 167(4), 2001, pp. 2130-2141
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (vol 6, pg 1167, 2000)
Authors: Bielekova, B Goodwin, B Richert, N Cortese, I Kondo, T Afshar, G Gran, B Eaton, J Antel, J Frank, JA McFarland, HF Martin, R
Citation: B. Bielekova et al., Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (vol 6, pg 1167, 2000), NAT MED, 6(12), 2000, pp. 1412-1412
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
Authors: Bielekova, B Goodwin, B Richert, N Cortese, I Kondo, T Afshar, G Gran, B Eaton, J Antel, J Frank, JA McFarland, HF Martin, R
Citation: B. Bielekova et al., Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand, NAT MED, 6(10), 2000, pp. 1167-1175
Minimal peptide length requirements for CD4(+) T cell clones - implications for molecular mimicry and T cell survival
Authors: Hemmer, B Kondo, T Gran, B Pinilla, C Cortese, I Pascal, J Tzou, A McFarland, HF Houghten, R Martin, R
Citation: B. Hemmer et al., Minimal peptide length requirements for CD4(+) T cell clones - implications for molecular mimicry and T cell survival, INT IMMUNOL, 12(3), 2000, pp. 375-383
Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis
Authors: Ballerini, C Campani, D Rambola, G Gran, B Nacmias, B Amato, MP Siracusa, G Bartolozzi, L Sorbi, S Massacesi, L
Citation: C. Ballerini et al., Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis, NEUROSCI L, 296(2-3), 2000, pp. 174-176
Mechanisms of immunomodulation by glatiramer acetate
Authors: Gran, B Tranquill, LR Chen, M Bielekova, B Zhou, W Dhib-Jalbut, S Martin, R
Citation: B. Gran et al., Mechanisms of immunomodulation by glatiramer acetate, NEUROLOGY, 55(11), 2000, pp. 1704-1714
Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency
Authors: Hemmer, B Pinilla, C Gran, B Vergelli, M Ling, N Conlon, P McFarland, HF Houghten, R Martin, R
Citation: B. Hemmer et al., Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency, J IMMUNOL, 164(2), 2000, pp. 861-871
Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease
Authors: Hemmer, B Gran, B Zhao, YD Marques, A Pascal, J Tzou, A Kondo, T Cortese, I Bielekova, B Straus, SE McFarland, HF Houghten, R Simon, R Pinilla, C Martin, R
Citation: B. Hemmer et al., Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease, NAT MED, 5(12), 1999, pp. 1375-1382
Exploring immunological specificity using synthetic peptide combinatorial libraries
Authors: Pinilla, C Martin, R Gran, B Appel, JR Boggiano, C Wilson, DB Houghten, RA
Citation: C. Pinilla et al., Exploring immunological specificity using synthetic peptide combinatorial libraries, CURR OP IM, 11(2), 1999, pp. 193-202
Molecular mimicry and multiple sclerosis: Degenerate T-Cell recognition and the induction of autoimmunity
Authors: Gran, B Hemmer, B Vergelli, M McFarland, HF Martin, R
Citation: B. Gran et al., Molecular mimicry and multiple sclerosis: Degenerate T-Cell recognition and the induction of autoimmunity, ANN NEUROL, 45(5), 1999, pp. 559-567
Molecular mimicry and multiple sclerosis - a possible role for degenerate T cell recognition in the induction of autoimmune responses
Authors: Gran, B Hemmer, B Martin, R
Citation: B. Gran et al., Molecular mimicry and multiple sclerosis - a possible role for degenerate T cell recognition in the induction of autoimmune responses, J NEUR TR-S, (55), 1999, pp. 19-31
Studying side effects of dental amalgam
Authors: Dalen, P Gran, B
Citation: P. Dalen et B. Gran, Studying side effects of dental amalgam, SC J PRIM H, 17(2), 1999, pp. 127-128
European integration in social and historical perspective from 1850 to thepresent
Authors: Gran, B
Citation: B. Gran, European integration in social and historical perspective from 1850 to thepresent, CONT SOCIOL, 28(2), 1999, pp. 215-216
Parting at the crossroads: The emergence of health insurance in the UnitedStates and Canada.
Authors: Gran, B
Citation: B. Gran, Parting at the crossroads: The emergence of health insurance in the UnitedStates and Canada., AM J SOCIOL, 105(3), 1999, pp. 907-908
Risultati: 1-16 |